Peter Abbink

10.3k total citations
43 papers, 2.7k citations indexed

About

Peter Abbink is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Peter Abbink has authored 43 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 20 papers in Infectious Diseases and 19 papers in Genetics. Recurrent topics in Peter Abbink's work include Virus-based gene therapy research (19 papers), HIV Research and Treatment (14 papers) and Virology and Viral Diseases (13 papers). Peter Abbink is often cited by papers focused on Virus-based gene therapy research (19 papers), HIV Research and Treatment (14 papers) and Virology and Viral Diseases (13 papers). Peter Abbink collaborates with scholars based in United States, Netherlands and United Kingdom. Peter Abbink's co-authors include Dan H. Barouch, Keith G. Mansfield, Diana M. Lynch, Jaap Goudsmit, Menzo Havenga, Angela Carville, Kara L. O’Brien, Angelique A. C. Lemckert, Jinyan Liu and Bonnie A. Ewald and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Peter Abbink

43 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Abbink United States 25 1.0k 1.0k 996 876 850 43 2.7k
Maria Grazia Pau Netherlands 23 765 0.7× 1.1k 1.1× 535 0.5× 734 0.8× 798 0.9× 51 2.4k
Zhiquan Xiang United States 27 1.2k 1.1× 876 0.9× 526 0.5× 836 1.0× 902 1.1× 49 2.5k
Darci A. Gorgone United States 25 1.1k 1.1× 1.0k 1.0× 1.5k 1.5× 1.1k 1.2× 1.7k 2.0× 30 3.4k
Diana M. Lynch United States 16 1.1k 1.1× 645 0.6× 795 0.8× 890 1.0× 772 0.9× 16 2.2k
Paul Chaplin Switzerland 35 441 0.4× 658 0.7× 1.4k 1.5× 1.3k 1.5× 1.3k 1.5× 71 3.2k
Stefano Colloca Italy 26 565 0.5× 434 0.4× 300 0.3× 593 0.7× 514 0.6× 54 2.0k
Jerry L. Blackwell United States 20 638 0.6× 466 0.5× 449 0.5× 650 0.7× 425 0.5× 36 1.8k
Angela Carville United States 14 700 0.7× 566 0.6× 881 0.9× 652 0.7× 797 0.9× 15 1.9k
Michael P. Dempsey United States 13 707 0.7× 1.2k 1.1× 1.9k 1.9× 1.1k 1.2× 752 0.9× 23 2.8k
Kelledy Manson United States 31 397 0.4× 667 0.7× 1.9k 1.9× 925 1.1× 2.1k 2.5× 47 3.7k

Countries citing papers authored by Peter Abbink

Since Specialization
Citations

This map shows the geographic impact of Peter Abbink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Abbink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Abbink more than expected).

Fields of papers citing papers by Peter Abbink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Abbink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Abbink. The network helps show where Peter Abbink may publish in the future.

Co-authorship network of co-authors of Peter Abbink

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Abbink. A scholar is included among the top collaborators of Peter Abbink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Abbink. Peter Abbink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinot, Amanda J., Freek Cox, Peter Abbink, et al.. (2024). Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection. npj Vaccines. 9(1). 157–157. 1 indexed citations
2.
Larocca, Rafael A., Peter Abbink, John D. Ventura, et al.. (2021). Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice. PLoS Pathogens. 17(6). e1009673–e1009673. 7 indexed citations
3.
Liu, Po-Ting, Brandon F. Keele, Peter Abbink, et al.. (2020). Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation. Nature Communications. 11(1). 5412–5412. 11 indexed citations
4.
Tartaglia, Lawrence J., Alexander Badamchi-Zadeh, Peter Abbink, et al.. (2019). Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo. PLoS Pathogens. 15(12). e1008180–e1008180. 11 indexed citations
5.
Abbink, Peter, Noe B. Mercado, Joseph P. Nkolola, et al.. (2019). Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques. Science. 365(6457). 1029–1033. 18 indexed citations
6.
Grubor‐Bauk, Branka, Danushka K. Wijesundara, Makutiro G. Masavuli, et al.. (2019). NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice. Science Advances. 5(12). eaax2388–eaax2388. 61 indexed citations
7.
Larocca, Rafael A., Érica Araújo Mendes, Peter Abbink, et al.. (2019). Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR−/− Mice. Cell Host & Microbe. 26(5). 591–600.e4. 26 indexed citations
8.
Badamchi-Zadeh, Alexander, Kelly D. Moynihan, Rafael A. Larocca, et al.. (2018). Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy. The Journal of Immunology. 201(9). 2744–2752. 14 indexed citations
9.
Abbink, Peter, Rafael A. Larocca, Wanwisa Dejnirattisai, et al.. (2018). Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys. Nature Medicine. 24(6). 721–723. 32 indexed citations
10.
Abbink, Peter, Kathryn E. Stephenson, & Dan H. Barouch. (2018). Zika virus vaccines. Nature Reviews Microbiology. 16(10). 594–600. 79 indexed citations
11.
Whitney, James B., So‐Yon Lim, Christa E. Osuna, et al.. (2018). Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy. Nature Communications. 9(1). 5429–5429. 44 indexed citations
12.
Stephenson, Kathryn E., Michael C. Keefer, Catherine A. Bunce, et al.. (2018). First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. PLoS ONE. 13(11). e0205139–e0205139. 28 indexed citations
13.
Cox, Freek, Leslie van der Fits, Peter Abbink, et al.. (2018). Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge. PLoS ONE. 13(8). e0202820–e0202820. 44 indexed citations
14.
Keele, Brandon F., Wenjun Li, Erica N. Borducchi, et al.. (2017). Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys. Nature Communications. 8(1). 15740–15740. 6 indexed citations
15.
Jülg, Boris, Po-Ting Liu, Kshitij Wagh, et al.. (2017). Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Science Translational Medicine. 9(408). 96 indexed citations
16.
Larocca, Rafael A., Nicholas M. Provine, Malika Aïd, et al.. (2016). Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4 + T cell responses that impair CD8 + T cell function. Science Immunology. 1(5). 16 indexed citations
17.
DeMuth, Peter C., Peter Abbink, Jinyan Liu, et al.. (2013). Vaccine delivery with microneedle skin patches in nonhuman primates. Nature Biotechnology. 31(12). 1082–1085. 5 indexed citations
18.
Barouch, Dan H., Jinyan Liu, Lauren Peter, et al.. (2012). Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001). The Journal of Infectious Diseases. 207(2). 248–256. 75 indexed citations
19.
Barouch, Dan H., Jinyan Liu, Diana M. Lynch, et al.. (2009). Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys. Journal of Virology. 83(18). 9584–9590. 26 indexed citations
20.
Liu, Jinyan, Bonnie A. Ewald, Diana M. Lynch, et al.. (2008). Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys. Journal of Virology. 82(10). 4844–4852. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026